Structural and functional studies of the ganglisoide binding activities of tetanus toxin

Structural and functional studies of the ganglisoide binding activities of tetanus toxin

Bibliografiska uppgifter
Huvudupphovsmän:	Fairweather, N, Sinha, K, Black, I, Emsley, P, Fotinou, C, Isaacs, N
Materialtyp:	Journal article
Publicerad:	2002

Liknande verk

The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding.
av: Emsley, P, et al.
Publicerad: (2000)

The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.
av: Fotinou, C, et al.
Publicerad: (2001)

Tetanus.
av: Farrar, J, et al.
Publicerad: (2000)

Tetanus toxin: importance and characteristic
av: Heidi Celina Oviedo Acevedo, et al.
Publicerad: (1999-04-01)

The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond.
av: Qazi, O, et al.
Publicerad: (2007)

Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test
av: Denise Cristina Souza Matos, et al.
Publicerad: (2002-09-01)

How does tetanus toxin act?
av: Mellanby, J, et al.
Publicerad: (1981)

Study of the tetanus toxin production by fermentation
av: J. Quintero, et al.
Publicerad: (2011-12-01)

Tetanus toxin as a tool for studying epilepsy.
av: Mellanby, J, et al.
Publicerad: (1984)

Tetanus Toxin C-Fragment: The Courier and the Cure?
av: Rosario Osta, et al.
Publicerad: (2010-10-01)

Updates on tetanus toxin: a fundamental approach
av: Md. Ahaduzzaman
Publicerad: (2015-03-01)

Botulinum toxin A for trismus in cephalic tetanus
av: Luiz Augusto F. Andrade, et al.
Publicerad: (1994-09-01)

Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production
av: Caroline Bayart, et al.
Publicerad: (2022-06-01)

Structural basis of tetanus toxin neutralization by native human monoclonal antibodies
av: Yueming Wang, et al.
Publicerad: (2021-05-01)

Tetanus: Pathophysiology, Treatment, and the Possibility of Using Botulinum Toxin against Tetanus-Induced Rigidity and Spasms
av: Bjørnar Hassel
Publicerad: (2013-01-01)

The monoclonal antibody 26 raised against tetanus toxoid also recognizes tetanus toxin and b2-glycoprotein I – its binding properties in vitro and potential applications
av: ALEKSANDRA B. INIĆ-KANADA, et al.
Publicerad: (2009-03-01)

The monoclonal antibody 26 raised against tetanus toxoid also recognizes tetanus toxin and β2-glycoprotein I - its binding properties in vitro and potential applications
av: Inić-Kanada Aleksandra B., et al.
Publicerad: (2009-01-01)

Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test
av: M.H. Sonobe, et al.
Publicerad: (2007-01-01)

Modeling the Interictal Epileptic State for Therapeutic Development with Tetanus Toxin
av: Faezeh Eslami, et al.
Publicerad: (2024-06-01)

Predicting the clinical outcome of tetanus: the tetanus severity score.
av: Thwaites, C, et al.
Publicerad: (2006)

Is there retrograde axonal transport of tetanus toxin in both alpha and beta fibres?
av: Green, J, et al.
Publicerad: (1977)

Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
av: Kexuan Cheng, et al.
Publicerad: (2024-12-01)

Confocal Endomicroscopy of Neuromuscular Junctions Stained with Physiologically Inert Protein Fragments of Tetanus Toxin
av: Cornelia Roesl, et al.
Publicerad: (2021-10-01)

Dynamic multiday seizure cycles and evolving rhythms in a tetanus toxin rat model of epilepsy
av: Parvin Zarei Eskikand, et al.
Publicerad: (2025-02-01)

In Silico Modeling and Production of New Vaccine Consisting of E7 Antigen Conjugated with Tetanus Toxin
av: M Jokar, et al.
Publicerad: (2017-01-01)

Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model
av: Laura Moreno-Martinez, et al.
Publicerad: (2020-05-01)

LOW DOSE TETANUS TOXIN INJECTIONS INTO THE RAT BASAL GANGLIA IMPAIR MOTOR PERFORMANCE
av: Patrik Meglić, et al.
Publicerad: (2023-10-01)

Tetanus toxin fragments and Bcl-2 fusion proteins: cytoprotection and retrograde axonal migration
av: Yasuhiro Watanabe, et al.
Publicerad: (2018-06-01)

Urinary catecholamine excretion in tetanus.
av: Thwaites, C, et al.
Publicerad: (2006)

Intrathecal serotherapy of tetanus. I. Explanation of complications. II. Comparison of intrathecal tetanus immune globulin and tetanus antitoxin
av: I Ildirim
Publicerad: (1974-07-01)

Tetanus
av: Thwaites, G, et al.
Publicerad: (2012)

Maternal and neonatal tetanus.
av: Thwaites, C, et al.
Publicerad: (2015)

Ocular tetanus
av: Muddappa T, et al.
Publicerad: (1982-01-01)

Penggunaan Anti Tetanus Serum dan Human Tetanus Immunoglobulin pada Tetanus Anak
av: Martinus M. Leman, et al.
Publicerad: (2016-11-01)

The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity
av: Rui Yu, et al.
Publicerad: (2020-01-01)

Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease
av: Mireia Herrando-Grabulosa, et al.
Publicerad: (2020-10-01)

Tetanus Toxin <italic toggle="yes">cis</italic>-Loop Contributes to Light-Chain Translocation
av: Madison Zuverink, et al.
Publicerad: (2020-06-01)

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine
av: C. Panpitpat, et al.
Publicerad: (2000-03-01)

Structural basis of pore formation by cholesterol-binding toxins
av: Gilbert, R, et al.
Publicerad: (2000)

Structural basis of pore formation by cholesterol-binding toxins.
av: Gilbert, R, et al.
Publicerad: (2000)